A carregar...
Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes
OBJECTIVE: Rebamipide ophthalmic suspension was developed for the treatment of dry eyes and for other corneal diseases, promoting the secretion of both mucin in tear fluid and membrane-associated mucin, increasing the number of goblet cells, and restoring the barrier function of the corneal epitheli...
Na minha lista:
| Publicado no: | Int Med Case Rep J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872273/ https://ncbi.nlm.nih.gov/pubmed/27257394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S103299 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|